Eventos Adversos de Influenza en Pacientes con Artritis Reumatoide, Colitis Ulcerosa o Pacientes con Artritis Psoriásica en los Programas de Desarrollo Clínico de Tofacitinib
Rheumatol Ther. 2022. Epub ahead of print doi: 10.1007/s40744-022-00507-z
This post-hoc analysis of 31 clinical trials in ulcerative colitis, rheumatoid arthritis and psoriatic arthritis concludes that combined influenza adverse event incidence rates were highest in ulcerative colitis, while in each indication they were generally similar across tofacitinib, placebo, and comparator groups.